OM Pharma

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

OM Pharma is a Swiss biopharmaceutical company headquartered in Geneva. The company develops, manufactures and commercialises medicines in areas including respiratory tract infections, urinary tract infections and vascular diseases. It is active in more than 100 countries and its portfolio includes bacterial lysates based products, such as OM-85 and OM-89, as well as other established pharmaceutical products. In 2020, the company became part of Optimus Holding, led by Etienne Jornod. In 2021, OM Pharma received the Geneva Economy Award. OM Pharma is the only pharmaceutical company that manufactures in Geneva.

OM Pharma is a Swiss biopharmaceutical company headquartered in Geneva. The company develops, manufactures and commercialises medicines in areas including respiratory tract infections, urinary tract infections and vascular diseases. It is active in more than 100 countries and its portfolio includes bacterial lysates based products, such as OM-85 and OM-89, as well as other established pharmaceutical products. In 2020, the company became part of Optimus Holding, led by Etienne Jornod. In 2021, OM Pharma received the Geneva Economy Award. OM Pharma is the only pharmaceutical company that manufactures in Geneva.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1365589039 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

23 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.